Article
Spironolactone for ME/CFS in a Patient Homozygous for rs5522 (I180V): A Case Report
2026-02-09
Abstract excerpt
<h4>Background: </h4> Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating condition with no consistently effective treatment. The mineralocorticoid receptor variant rs5522 (I180V) is associated with enhanced MR response to cortisol and altered stress responsiveness, but has not been linked to ME/CFS treatment response. Case: A 48-year-old woman with 28 years of treatment-resistant ME/CFS...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- cd5419a6-97b8-5bf0-beec-c974cf1d0fa1
- DOI
- 10.22541/au.177067531.10473859/v1
